サンベタゾン眼耳鼻科用液０．１％
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB00443 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 100 |
| 日本商品名（例） | サンベタゾン眼耳鼻科用液０．１％, ステロネマ注腸１．５ｍｇ １．９７５ｍｇ, ステロネマ注腸３ｍｇ ３．９５ｍｇ |
承認適応症（KEGG）
乾癬、掌蹠膿疱症、扁平苔癬、毛孔性紅色粃糠疹、ジベルバラ色粃糠疹、慢性円板状エリテマトーデス、凍瘡、天疱瘡群、ジューリング疱疹状皮膚炎、類天疱瘡
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | miliary tuberculosis | 99% | DL |
| 2 | adrenocortical insufficiency | 99% | DL |
| 3 | nephrotic syndrome | 99% | DL |
| 4 | acquired thrombocytopenia | 99% | DL |
| 5 | granulomatous slack skin disease | 99% | DL |
| 6 | alopecia areata | 99% | DL |
| 7 | alopecia mucinosa | 99% | DL |
| 8 | telogen effluvium | 99% | DL |
| 9 | Quinquaud's folliculitis decalvans | 99% | DL |
| 10 | alopecia antibody deficiency | 99% | DL |
| 11 | hereditary hypotrichosis with recurrent skin vesicles | 99% | DL |
| 12 | alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome | 99% | DL |
| 13 | atrichia with papular lesions | 99% | DL |
| 14 | idiopathic steroid-sensitive nephrotic syndrome | 99% | DL |
| 15 | sporadic idiopathic steroid-resistant nephrotic syndrome | 99% | DL |
| 16 | alopecia universalis onychodystrophy vitiligo | 99% | DL |
| 17 | rheumatic heart disease | 98% | DL |
| 18 | heparin-induced thrombocytopenia (disease) | 98% | DL |
| 19 | autoimmune hemolytic anemia | 98% | DL |
| 20 | fetal erythroblastosis | 98% | DL |
| 21 | Addison disease | 98% | DL |
| 22 | tenosynovitis | 98% | DL |
| 23 | familial adrenal hypoplasia with absent pituitary luteinizing hormone | 98% | DL |
| 24 | Stevens-Johnson syndrome | 98% | DL |
| 25 | necrobiosis lipoidica | 98% | DL |
| 26 | autoimmune myocarditis | 98% | DL |
| 27 | disorder of GPI anchor biosynthesis | 98% | DL |
| 28 | 46,XY disorder of sex development | 98% | DL |
| 29 | Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome | 98% | DL |
| 30 | PAGOD syndrome | 98% | DL |
| 31 | Trichinellosis | 97% | DL |
| 32 | seborrheic keratosis | 97% | DL |
| 33 | disease of orbital region | 97% | DL |
| 34 | epicondylitis | 97% | DL |
| 35 | acquired aplastic anemia | 97% | DL |
| 36 | hemoglobinuria | 97% | DL |
| 37 | disease of orbital part of eye adnexa | 97% | DL |
| 38 | nephrotic syndrome ocular anomalies | 97% | DL |
| 39 | cystic teratoma | 97% | DL |
| 40 | spinal cord dermoid cyst | 97% | DL |
| 41 | dermoid cyst of ovary | 97% | DL |
| 42 | subacute bursitis | 97% | DL |
| 43 | persistent polyclonal B-cell lymphocytosis | 97% | DL |
| 44 | punctate epithelial keratoconjunctivitis | 97% | DL |
| 45 | nephrotic syndrome of childhood - steroid sensitive | 97% | DL |
| 46 | gout | 96% | DL |
| 47 | chronic primary adrenal insufficiency | 96% | DL |
| 48 | inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | 96% | DL |
| 49 | mantle cell lymphoma | 96% | DL |
| 50 | exostosis | 96% | DL |
（上位50件を表示。全100件の予測があります）
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。